Aktuelle Ernährungsmedizin 2007; 32: S89-S92
DOI: 10.1055/s-2006-951880
Leitlinie Parenterale Ernährung der DGEM
© Georg Thieme Verlag KG Stuttgart · New York

14 Intensivmedizin

G.  Kreymann (AG-Leiter), M.  Adolph, W.  Druml, K.  W.  Jauch
Further Information

Publication History

Publication Date:
04 March 2008 (online)

Literatur

  • 1 Braunschweig C L, Levy P, Sheean P M, Wang X. Enteral compared with parenteral nutrition: a meta-analysis.  Am J Clin Nutr. 2001;  74 534-542
  • 2 Bertolini G, Iapichino G, Radrizzani D. et al . Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial.  Intensive Care Med. 2003;  29 834-840
  • 3 Woodcock N P, Zeigler D, Palmer M D, Buckley P, Mitchell C J, MacFie J. Enteral versus parenteral nutrition: a pragmatic study.  Nutrition. 2001;  17 1-12
  • 4 Sandstrom R, Drott C, Hyltander A. et al . The effect of postoperative intravenous feeding (TPN) on outcome following major surgery evaluated in a randomized study.  Ann Surg. 1993;  217 185-195
  • 5 Tappy L, Schwarz J M, Schneiter P. et al . Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients.  Crit Care Med. 1998;  26 860-867
  • 6 Battistella F D, Widergren J T, Anderson J T, Siepler J K, Weber J C, MacColl K. A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition.  J Trauma. 1997;  43 52-58
  • 7 Heyland D K, MacDonald S, Keefe L, Drover J W. Total parenteral nutrition in the critically ill patient: a meta-analysis.  JAMA. 1998;  280 2013-2019
  • 8 Berghe G Van den, Wouters P, Weekers F. et al . Intensive insulin therapy in the critically ill patients.  N Engl J Med. 2001;  345 1359-1367
  • 9 Finney S J, Zekveld C, Elia A, Evans T W. Glucose control and mortality in critically ill patients.  JAMA. 2003;  290 2041-2047
  • 10 Berghe G Van den, Wouters P J, Bouillon R. et al . Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.  Crit Care Med. 2003;  31 359-366
  • 11 Seron A C, Avellanas C M, Homs G C, Larraz V A, Laplaza M J, Puzo F J. Evaluation of a high protein diet in critical care patients.  Nutr Hosp. 1999;  14 203-209
  • 12 Ishibashi N, Plank L D, Sando K, Hill G L. Optimal protein requirements during the first 2 weeks after the onset of critical illness.  Crit Care Med. 1998;  26 1529-1535
  • 13 Heijden A van der, Verbeek M J, Schreurs V V, Akkermans L M, Vos A. Effect of increasing protein ingestion on the nitrogen balance of mechanically ventilated critically ill patients receiving total parenteral nutrition.  Nutr Hosp. 1993;  8 279-287
  • 14 Larsson J, Lennmarken C, Martensson J, Sandstedt S, Vinnars E. Nitrogen requirements in severely injured patients.  Br J Surg. 1990;  77 413-416
  • 15 Wolfe R R, Goodenough R D, Burke J F, Wolfe M H. Response of protein and urea kinetics in burn patients to different levels of protein intake.  Ann Surg. 1983;  197 163-171
  • 16 Schmitz J E, Lotz P, Ahnefeld F W, Grunert A. Protein and energy metabolism in intensive care patients.  Infusionsther Klin Ernähr. 1981;  8 158-162
  • 17 Scheinkestel C D, Kar L, Marshall K. et al . Prospective randomized trial to assess caloric and protein needs of critically ill, anuric, ventilated patients requiring continuous renal replacement therapy.  Nutrition. 2003;  19 909-916
  • 18 Hoffer L J. Protein and energy provision in critical illness.  Am J Clin Nutr. 2003;  78 906-911
  • 19 Novak F, Heyland D K, Avenell A, Drover J W, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence.  Crit Care Med. 2002;  30 2022-2029
  • 20 Wischmeyer P E, Lynch J, Liedel J. et al . Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control.  Crit Care Med. 2001;  29 2075-2080
  • 21 Fuentes-Orozco C, Anaya-Prado R, Gonzalez-Ojeda A. et al . L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis.  Clin Nutr. 2004;  23 13-21
  • 22 Goeters C, Wenn A, Mertes N. et al . Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients.  Crit Care Med. 2002;  30 2032-2037
  • 23 Griffiths R D, Jones C, Palmer T E. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition.  Nutrition. 1997;  13 295-302
  • 24 Powell-Tuck J, Jamieson C P, Bettany G E. et al . A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition.  Gut. 1999;  45 82-88
  • 25 Freund H R, Hanani M. The metabolic role of branched-chain amino acids.  Nutrition. 2002;  18 287-288
  • 26 Garcia-de-Lorenzo A, Ortiz-Leyba C, Planas M. et al . Parenteral administration of different amounts of branch-chain amino acids in septic patients: clinical and metabolic aspects.  Crit Care Med. 1997;  25 418-424
  • 27 Wang X Y, Li N, Gu J, Li W Q, Li J S. The effects of the formula of amino acids enriched BCAA on nutritional support in traumatic patients.  World J Gastroenterol. 2003;  9 599-602